Matthew Greenhawt, M.D., MBA, MSc (Chair)

Matthew Greenhawt, MD, MBA, MSc, is a professor in the Department of Pediatrics Section of Allergy and Immunology at Children’s Hospital Colorado and the University of Colorado School of Medicine, and is the director for the Children’s Hospital Colorado Food Challenge and Research Unit in Aurora, CO. Dr Greenhawt earned his medical degree from Tufts University School of Medicine in Boston, MA. He then completed his residency in pediatrics at Morgan Stanley Children’s Hospital of New York-Presbyterian, Columbia Presbyterian Medical Center in New York, NY and his fellowship in allergy/immunology at the University of Michigan in Ann Arbor, MI. He also holds an MBA from Tufts University and a MS degree in health and healthcare policy from the University of Michigan, Rackham School of Graduate Studies. Dr Greenhawt is board certified in pediatrics and allergy/immunology.

Dr Greenhawt’s research interests include shared decision making, food allergy cost-effectiveness and comparative effectiveness research, food-allergic diseases health services research, primary/secondary prevention and treatment of food allergy, and food allergy public policy.

Dr Greenhawt has authored a number of peer-reviewed articles, abstracts, and book chapters. He is the senior associate editor for the Annals of Allergy, Asthma and Immunology, and a member of the Joint Taskforce of Allergy Practice Parameters. Dr Greenhawt is a member of many professional organizations, including the American Academy of Allergy, Asthma & Immunology, the American Academy of Pediatrics, the American College of Allergy, Asthma & Immunology, and the European Academy of Allergy and Clinical Immunology. He is also involved with many committees, including the Brighton Collaboration Criteria Vaccine Anaphylaxis Case Definition 2.0 work group, multiple AAAAI and EAACI committees, and is the former chair of the ACAAI Food Allergy Committee.

Please complete this form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing info@aquestive.com or by calling 1-908-941-1900.
  • This field is for validation purposes and should be left unchanged.

Please complete the form below and click SEND to receive a copy of “Overcoming Solubility and Permeability Challenges,” a case study detailing the achievements made by Aquestive’s formulation team to create the diazepam buccal film.

  • To subscribe to receive marketing updates about diazepam buccal film and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form to receive a demonstration kit for our PharmFilm® technology.

  • To subscribe to receive marketing updates about our PharmFilm® technology and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete this form:

  • To subscribe to receive marketing updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing clinicaltrials@aquestive.com.

Whether we are partnering to out license our PharmFilm® technology or in-licensing adjacent assets, Aquestive works hand-in-hand with our partners to address their toughest clinical and business challenges. To learn more, please complete the following form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form below and click submit to receive a copy of “The Art of LGS Book.”

Please complete our short form to speak with a business development specialist.